Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

References for PMC Articles for PubMed (Select 20405005)

1.

Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo.

Schaaf C, Shan B, Buchfelder M, Losa M, Kreutzer J, Rachinger W, Stalla GK, Schilling T, Arzt E, Perone MJ, Renner U.

Endocr Relat Cancer. 2009 Dec;16(4):1339-50. doi: 10.1677/ERC-09-0129. Epub 2009 Sep 2.

2.

Estradiol increases the Bax/Bcl-2 ratio and induces apoptosis in the anterior pituitary gland.

Zaldivar V, Magri ML, Zárate S, Jaita G, Eijo G, Radl D, Ferraris J, Pisera D, Seilicovich A.

Neuroendocrinology. 2009;90(3):292-300. doi: 10.1159/000235618. Epub 2009 Aug 14.

PMID:
19684383
3.

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, Reincke M, Snyder P, Tabarin A, Biller BM, Findling J, Melmed S, Darby CH, Hu K, Wang Y, Freda PU, Grossman AB, Frohman LA, Bertherat J.

J Clin Endocrinol Metab. 2009 Jan;94(1):115-22. doi: 10.1210/jc.2008-1008. Epub 2008 Oct 28.

PMID:
18957506
4.

Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.

Miller M, Chen S, Woodliff J, Kansra S.

Endocrinology. 2008 Aug;149(8):4158-67. doi: 10.1210/en.2007-1760. Epub 2008 May 1.

5.
8.

Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer.

Ohori H, Yamakoshi H, Tomizawa M, Shibuya M, Kakudo Y, Takahashi A, Takahashi S, Kato S, Suzuki T, Ishioka C, Iwabuchi Y, Shibata H.

Mol Cancer Ther. 2006 Oct;5(10):2563-71.

9.

Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells.

Ezzat S, Zhu X, Loeper S, Fischer S, Asa SL.

Mol Endocrinol. 2006 Nov;20(11):2976-86. Epub 2006 Jul 27.

PMID:
16873443
10.

Curcumin: getting back to the roots.

Shishodia S, Sethi G, Aggarwal BB.

Ann N Y Acad Sci. 2005 Nov;1056:206-17.

PMID:
16387689
11.
12.

Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.

Kansra S, Yamagata S, Sneade L, Foster L, Ben-Jonathan N.

Mol Cell Endocrinol. 2005 Jul 15;239(1-2):27-36.

PMID:
15950373
13.

Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma.

Miyoshi T, Otsuka F, Takeda M, Inagaki K, Suzuki J, Ogura T, Date I, Hashimoto K, Makino H.

J Endocrinol Invest. 2004 Dec;27(11):1055-9.

PMID:
15754738
14.

Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2.

Syng-Ai C, Kumari AL, Khar A.

Mol Cancer Ther. 2004 Sep;3(9):1101-8.

15.

Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells.

Collett GP, Campbell FC.

Carcinogenesis. 2004 Nov;25(11):2183-9. Epub 2004 Jul 15.

16.

Expression of Bcl-2, Bax and p53 proteins in pituitary adenomas: an immunohistochemical study.

Ozer E, Canda MS, Ulukus C, Guray M, Erbayraktar S.

Tumori. 2003 Jan-Feb;89(1):54-9.

PMID:
12729363
17.

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.

Heaney AP, Fernando M, Yong WH, Melmed S.

Nat Med. 2002 Nov;8(11):1281-7. Epub 2002 Oct 15.

PMID:
12379847
18.

Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells.

Suh J, Payvandi F, Edelstein LC, Amenta PS, Zong WX, Gélinas C, Rabson AB.

Prostate. 2002 Aug 1;52(3):183-200.

PMID:
12111695
19.

Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways.

Kirito K, Watanabe T, Sawada K, Endo H, Ozawa K, Komatsu N.

J Biol Chem. 2002 Mar 8;277(10):8329-37. Epub 2001 Dec 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk